Related Experiment Video
Updated: May 11, 2026

08:39
Stereotaxic Injection of a Viral Vector for Conditional Gene Manipulation in the Mouse Spinal Cord
Published on: March 18, 2013
Engineering herpes simplex virus vectors for gene transfer to neurons
1Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania & VA Medical Center, Pittsburgh, Pennsylvania, USA.
Nature Medicine
|March 1, 1997
Summary
Herpes simplex virus (HSV) vectors show promise for brain gene therapy. Their natural ability to infect neurons facilitates efficient gene transfer and expression, with ongoing research improving safety and efficacy for neurological applications.
Area of Science:
- Neurovirology
- Gene Therapy
- Molecular Biology
Background:
- Herpes simplex virus (HSV) possesses a unique natural tropism for neurons.
- This viral characteristic enables efficient gene transfer and sustained gene expression within neural cells.
- Understanding HSV's interaction with neurons is crucial for developing advanced gene delivery systems.
Purpose of the Study:
- To explore the potential of HSV-based vectors for effective transgene expression in the brain.
- To leverage the natural neuronal-targeting and gene expression capabilities of HSV for therapeutic applications.
- To investigate advancements in developing safer and more efficient HSV vectors for neurological gene therapy.
Main Methods:
- Development of defective viral mutants with reduced cytotoxicity.
- Investigation of the viral genome's state during latency.
- Analysis of the functional elements within the HSV latency promoter system.
Main Results:
- Progress in creating less toxic viral vectors.
- Enhanced understanding of viral latency mechanisms.
- Identification of key regulatory elements for sustained gene expression.
Conclusions:
- HSV vectors can be engineered to exploit their natural neuronal affinity for effective gene delivery to the brain.
- Further development of HSV vectors holds significant potential for treating neurological disorders through targeted gene expression.
- Optimized HSV vectors offer a promising platform for long-term transgene expression in neural tissues.

